Notice: Function WP_Scripts::add was called incorrectly. The script with the handle "jquery" was enqueued with dependencies that are not registered: jquery-migrate. Please see Debugging in WordPress for more information. (This message was added in version 6.9.1.) in /var/www/vhosts/hemostasistoday.com/public_html/wp-includes/functions.php on line 6131

Hemostasis Today

February, 2026
February 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
232425262728  
Melanie Daniel: A Landmark Session on Hemophilia and Rare Bleeding Disorders at the National Academy of Medicine
Feb 5, 2026, 17:20

Melanie Daniel: A Landmark Session on Hemophilia and Rare Bleeding Disorders at the National Academy of Medicine

Melanie Daniel, Physician at Lille University Hospital, shared on LinkedIn:

”A landmark session on hemophilia and rare bleeding disorders at the National Academy of Medicine

Last week, the National Academy of Medicine hosted an outstanding public session dedicated to hemophilia and other rare bleeding disorders, bringing together clinical, translational, and therapeutic perspectives on a rapidly evolving field.

The session showcased major advances in patient management, innovative biology, gene therapy, and progress in rare disorders of hemostasis.

Scientific contributions included:
• Hemophilia and the evolution of patient management
Sophie Susen
• Nanobodies and therapeutic antibodies: a revolution
Peter Lenting
• Gene therapy in hemophilia
Antoine Rauch
• Advances in other rare hemostatic disorders
Cécile Denis

A great recognition of the work carried out by UMR1011 – Team 2, with the active participation of Prof. sophie susen and Prof. Antoine Rauch, and of the strength of long-standing scientific collaborations with Cécile DENIS and Peter Lenting at UMR1176 HITh lab Inserm.

Missed the session?
The full recording is available on the Academy’s YouTube channel.”

Melanie Daniel: A Landmark Session on Hemophilia and Rare Bleeding Disorders at the National Academy of Medicine

Stay updated with Hemostasis Today.